Hone Bio Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
20
Hone Bio General Information
Description
Developer of cell membrane augmentation technology designed to treat solid tumors. The company's technology enhances cell therapies for cancer, heart disease, osteoarthritis and diabetic wound healing, enabling researchers to add new functionalities to therapies, including tissue-specific targeting and enhanced cell survivability.
Contact Information
Website
www.hone.bioCorporate Office
- Science Creates Old Market
- Midland Road
- Bristol BS2 0JZ
- England, United Kingdom
Corporate Office
- Science Creates Old Market
- Midland Road
- Bristol BS2 0JZ
- England, United Kingdom
Hone Bio Timeline
Hone Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Accelerator/Incubator | 01-Jun-2025 | Completed | Generating Revenue | |||
| 10. Later Stage VC | 06-Sep-2023 | Completed | Generating Revenue | |||
| 9. Early Stage VC | 15-Mar-2021 | Completed | Generating Revenue | |||
| 8. Grant | 01-Jan-2020 | Completed | Generating Revenue | |||
| 7. Seed Round | 25-Nov-2019 | Completed | Generating Revenue | |||
| 6. Angel (individual) | Completed | Pre-Clinical Trials | ||||
| 5. Grant | 01-Feb-2018 | Completed | Pre-Clinical Trials | |||
| 4. Grant | 01-Jan-2018 | Completed | Pre-Clinical Trials | |||
| 3. Grant | 16-May-2017 | $2.58K | Completed | Pre-Clinical Trials | ||
| 2. Accelerator/Incubator | Completed | Pre-Clinical Trials |
Hone Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| B Ordinary | ||||||||
| B Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 490 | $0.126725 | $121.81 | $121.81 | 1x | $121.81 | 0.98% | |
| Ordinary | 5,827 | $0.126725 | $152.17 | $152.17 | 1x | $152.17 | 11.64% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Hone Bio Comparisons
Industry
Financing
Details
Hone Bio Competitors (2)
One of Hone Bio’s 2 competitors is Autolus, a Formerly VC-backed company based in London, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Autolus | Formerly VC-backed | London, United Kingdom | ||||
| Biosceptre | Venture Capital-Backed | Cambridge, United Kingdom |
Hone Bio Patents
Hone Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026052839-A1 | Targeting fusion proteins | Pending | 06-Sep-2024 | ||
| WO-2023144089-A1 | Carboxymethl dextran used as crosslinker in immunotherapy | Inactive | 25-Jan-2022 | ||
| GB-202200962-D0 | Polymer additives | Inactive | 25-Jan-2022 | ||
| AU-2020231078-A1 | Antitumor cell comprising a charge modified globin | Inactive | 06-Mar-2019 | ||
| CA-3131161-A1 | Antitumor cell comprising a charge modified globin | Pending | 06-Mar-2019 | A61K35/17 |
Hone Bio Signals
Hone Bio Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Science Creates | Accelerator/Incubator | |||
| KCP Nominees | Corporation | Minority | ||
| Luminous Ventures (Healthcare) | Venture Capital | Minority | ||
| Meltwind Advisory | Venture Capital | Minority | ||
| Outsized Ventures | Venture Capital | Minority |
Hone Bio FAQs
-
When was Hone Bio founded?
Hone Bio was founded in 2017.
-
Where is Hone Bio headquartered?
Hone Bio is headquartered in Bristol, United Kingdom.
-
What is the size of Hone Bio?
Hone Bio has 6 total employees.
-
What industry is Hone Bio in?
Hone Bio’s primary industry is Drug Discovery.
-
Is Hone Bio a private or public company?
Hone Bio is a Private company.
-
What is Hone Bio’s current revenue?
The current revenue for Hone Bio is .
-
How much funding has Hone Bio raised over time?
Hone Bio has raised $7.33M.
-
Who are Hone Bio’s investors?
Science Creates, KCP Nominees, Luminous Ventures (Healthcare), Meltwind Advisory, and Outsized Ventures are 5 of 20 investors who have invested in Hone Bio.
-
Who are Hone Bio’s competitors?
Autolus and Biosceptre are competitors of Hone Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process